Contributor:

AURA review of the real life experience

Frank G. Holz, MD, Sobha Sivaprasad, MD

Treatment Criteria for Ellex 2RT

David Lubeck, MD, David R. Chow, MD, Frank Holz, MD, Netan Choudhry, MD, FRCS(C), Rishi Singh, MD, Robyn Guymer, AM, MBBS, PhD

Identifying the Different Stages of AMD

David Lubeck, MD, David R. Chow, MD, Frank Holz, MD, Netan Choudhry, MD, FRCS(C), Rishi Singh, MD, Robyn Guymer, AM, MBBS, PhD

Discussing AMD and Treatment Options with Patients

David Lubeck, MD, David R. Chow, MD, Frank Holz, MD, Netan Choudhry, MD, FRCS(C), Rishi Singh, MD, Robyn Guymer, AM, MBBS, PhD

The LEAD Study and Application of Ellex 2RT

David Lubeck, MD, David R. Chow, MD, Frank Holz, MD, Netan Choudhry, MD, FRCS(C, Rishi Singh, MD, Robyn Guymer, AM, MBBS, PhD

Transitioning from Monitoring to Treating AMD

David Lubeck, MD, David R. Chow, MD, Frank Holz, MD, Netan Choudhry, MD, FRCS(C), Rishi Singh, MD, Robyn Guymer, AM, MBBS, PhD

Biosimilars in Retina

Ramin Tadayoni, MD, PhD, and Prof. Frank Holz

Ellex 2RT for Early AMD Intervention Roundtable

David Chow, MD, David Lubeck, MD, Frank Holz, MD, Netan Choudhry, MD, FRCS(C), Rishi P. Singh, MD, Robyn Guymer, AM, MBBS, PhD